Literature DB >> 25693836

Topoisomerase-mediated chromosomal break repair: an emerging player in many games.

Mohamed E Ashour1, Reham Atteya2, Sherif F El-Khamisy1.   

Abstract

The mammalian genome is constantly challenged by exogenous and endogenous threats. Although much is known about the mechanisms that maintain DNA and RNA integrity, we know surprisingly little about the mechanisms that underpin the pathology and tissue specificity of many disorders caused by defective responses to DNA or RNA damage. Of the different types of endogenous damage, protein-linked DNA breaks (PDBs) are emerging as an important player in cancer development and therapy. PDBs can arise during the abortive activity of DNA topoisomerases, a class of enzymes that modulate DNA topology during several chromosomal transactions, such as gene transcription and DNA replication, recombination and repair. In this Review, we discuss the mechanisms underpinning topoisomerase-induced PDB formation and repair with a focus on their role during gene transcription and the development of tissue-specific cancers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693836     DOI: 10.1038/nrc3892

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  175 in total

1.  Base excision repair intermediates as topoisomerase II poisons.

Authors:  A M Wilstermann; N Osheroff
Journal:  J Biol Chem       Date:  2001-10-08       Impact factor: 5.157

Review 2.  The ABCs of infant leukemia.

Authors:  Patrick A Zweidler-McKay; Joanne M Hilden
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008-03

3.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

Review 4.  Topoisomerase II and the etiology of chromosomal translocations.

Authors:  Carolyn A Felix; Christos P Kolaris; Neil Osheroff
Journal:  DNA Repair (Amst)       Date:  2006-07-20

Review 5.  Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer.

Authors:  Tero A H Järvinen; Edison T Liu
Journal:  Curr Cancer Drug Targets       Date:  2006-11       Impact factor: 3.428

Review 6.  Interfacial inhibitors: targeting macromolecular complexes.

Authors:  Yves Pommier; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

7.  Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia.

Authors:  Anna M Azarova; Ren-Kuo Lin; Yuan-Chin Tsai; Leroy F Liu; Chao-Po Lin; Yi Lisa Lyu
Journal:  Biochem Biophys Res Commun       Date:  2010-07-16       Impact factor: 3.575

8.  5-Arylidenethioxothiazolidinones as inhibitors of tyrosyl-DNA phosphodiesterase I.

Authors:  Venkata Ramana Sirivolu; Sanjeev Kumar V Vernekar; Christophe Marchand; Alena Naumova; Adel Chergui; Amelie Renaud; Andrew G Stephen; Feng Chen; Yuk Y Sham; Yves Pommier; Zhengqiang Wang
Journal:  J Med Chem       Date:  2012-10-08       Impact factor: 7.446

9.  Structure-specific endonucleases xpf and mus81 play overlapping but essential roles in DNA repair by homologous recombination.

Authors:  Koji Kikuchi; Takeo Narita; Van T Pham; Junko Iijima; Kouji Hirota; Islam Shamima Keka; Katsuya Okawa; Tetsuya Hori; Tatsuo Fukagawa; Jeroen Essers; Roland Kanaar; Matthew C Whitby; Kaoru Sugasawa; Yoshihito Taniguchi; Katsumi Kitagawa; Shunichi Takeda
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

Review 10.  Out of balance: R-loops in human disease.

Authors:  Matthias Groh; Natalia Gromak
Journal:  PLoS Genet       Date:  2014-09-18       Impact factor: 5.917

View more
  68 in total

1.  Single-molecule Förster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents.

Authors:  Wan-Chen Huang; Chun-Ying Lee; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

Review 2.  Topoisomerases and the regulation of neural function.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2016-09-15       Impact factor: 34.870

3.  ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links.

Authors:  Matthew J Schellenberg; Jenna Ariel Lieberman; Andrés Herrero-Ruiz; Logan R Butler; Jason G Williams; Ana M Muñoz-Cabello; Geoffrey A Mueller; Robert E London; Felipe Cortés-Ledesma; R Scott Williams
Journal:  Science       Date:  2017-09-14       Impact factor: 47.728

4.  Mitochondrial tyrosyl-DNA phosphodiesterase 2 and its TDP2S short isoform.

Authors:  Shar-Yin N Huang; Ilaria Dalla Rosa; Stephanie A Michaels; David V Tulumello; Keli Agama; Salim Khiati; Sae Rin Jean; Simone A Baechler; Valentina M Factor; Sudhir Varma; Junko Murai; Lisa M Miller Jenkins; Shana O Kelley; Yves Pommier
Journal:  EMBO Rep       Date:  2018-02-09       Impact factor: 8.807

5.  Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity.

Authors:  Christina A Gerodimos; Howard H Y Chang; Go Watanabe; Michael R Lieber
Journal:  J Biol Chem       Date:  2017-07-10       Impact factor: 5.157

Review 6.  Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication.

Authors:  Kristijan Ramadan; Swagata Halder; Katherine Wiseman; Bruno Vaz
Journal:  Chromosoma       Date:  2016-04-18       Impact factor: 4.316

7.  Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).

Authors:  Le-Mao Yu; Zhu Hu; Yu Chen; Azhar Ravji; Sophia Lopez; Caroline B Plescia; Qian Yu; Hui Yang; Monica Abdelmalak; Sourav Saha; Keli Agama; Evgeny Kiselev; Christophe Marchand; Yves Pommier; Lin-Kun An
Journal:  Eur J Med Chem       Date:  2018-04-12       Impact factor: 6.514

Review 8.  Molecular mechanisms of topoisomerase 2 DNA-protein crosslink resolution.

Authors:  Amanda A Riccio; Matthew J Schellenberg; R Scott Williams
Journal:  Cell Mol Life Sci       Date:  2019-11-15       Impact factor: 9.261

9.  A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.

Authors:  Rohith Srivas; John Paul Shen; Chih Cheng Yang; Su Ming Sun; Jianfeng Li; Andrew M Gross; James Jensen; Katherine Licon; Ana Bojorquez-Gomez; Kristin Klepper; Justin Huang; Daniel Pekin; Jia L Xu; Huwate Yeerna; Vignesh Sivaganesh; Leonie Kollenstart; Haico van Attikum; Pedro Aza-Blanc; Robert W Sobol; Trey Ideker
Journal:  Mol Cell       Date:  2016-07-21       Impact factor: 17.970

Review 10.  Processing ribonucleotides incorporated during eukaryotic DNA replication.

Authors:  Jessica S Williams; Scott A Lujan; Thomas A Kunkel
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-20       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.